Y-Intercept (HK)’s Niagen Bioscience NAGE Stock Holding History

Y-Intercept (HK)’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-39,301	Closed	-$137K	–	2018
2024 Q1	$137K	Buy	+39,301	New	+$72.7K	0.01%	1227

Other funds holding NAGE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Y-Intercept (HK)'s NAGE Position: Q2 2024 in Review

Y-Intercept (HK) sold out of Niagen Bioscience (NAGE) in Q2 2024, closing a stake of 39,301 shares — an estimated $137K sold.

Y-Intercept (HK) first reported a position in NAGE in Q1 2024 and held it in 1 quarter. The position peaked at $137K in Q1 2024. 78 funds tracked by Wall St. Rank hold NAGE as of Q2 2024.

Y-Intercept (HK) reported no remaining Niagen Bioscience position as of Q2 2024 after selling out during the quarter.
Y-Intercept (HK) sold 39,301 Niagen Bioscience shares in Q2 2024, an estimated $137K.
Y-Intercept (HK) first reported a position in Niagen Bioscience in Q1 2024 and held it in 1 quarter.
Y-Intercept (HK)'s Niagen Bioscience position peaked at $137K in Q1 2024.
78 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2024.

Based on Y-Intercept (HK)'s 13F filing for Q2 2024, filed 14 Aug 2024.